课题基金 / 基金详情

Human Leukocyte Antigen-A and -B regulation of Natural Killer cell function

Human Leukocyte Antigen-A and -B regulation of Natural Killer cell function
人类白细胞抗原 A 和 B 对自然杀伤细胞功能的调节
批准号:
DP230103117
负责人:
Prof Andrew Brooks
金额:
$57.06万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Discovery Projects
财政年份:
2023
资助国家:
澳大利亚
项目状态:
未结题
起止时间:
2023-01-01 至 2025-12-31

项目摘要

项目成果

Prof Andrew Brooks的其他基金

相似基金

相关文献

中文摘要
翻译
该项目的目的是确定编码天然淋巴细胞及其识别的分子表达的细胞表面受体的基因的遗传变异如何使其感知和应对感染的能力多样化。这些知识对于理解为什么个体之间在应对不同类型感染的能力方面存在内在差异至关重要,并最终将使我们有能力更好地部署个性化药物。
英文摘要
The aim of this project is to determine how genetic variation in the genes encoding cell surface receptors expressed by innate lymphocytes and the molecules they recognise diversifies their capacity to sense and respond to infection. This knowledge is critical for understanding why there are intrinsic differences between individuals with respect to their capacity to respond to different types of infection and will ultimately inform our capacity to better deploy personalised medicines.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Antigen presentation, recognition and the immune response
  • 批准号:
    nhmrc : 1113293
  • 项目类别:
    Program Grants
  • 资助金额:
    $1020.57万
  • 财政年份:
    2017
  • 负责人:
    Prof Andrew Brooks
  • 依托单位:
Antigen presentation, recognition and the immune response
  • 批准号:
    nhmrc : GNT1113293
  • 项目类别:
    Programs
  • 资助金额:
    $1492.7万
  • 财政年份:
    2017
  • 负责人:
    Prof Andrew Brooks
  • 依托单位:
Antigen presentation, recognition and the immune response
  • 批准号:
    nhmrc : 1016629
  • 项目类别:
    Program Grants
  • 资助金额:
    $1052.27万
  • 财政年份:
    2012
  • 负责人:
    Prof Andrew Brooks
  • 依托单位:
Antigen presentation, recognition and the immune response
  • 批准号:
    nhmrc : 454465
  • 项目类别:
    Programs
  • 资助金额:
    $1049.46万
  • 财政年份:
    2007
  • 负责人:
    Prof Andrew Brooks
  • 依托单位:
海外基金